@article{bonnet:hal-03660656,
TITLE = {Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group},
AUTHOR = {Bonnet, Christophe and Dupuis, Jehan and Tilly, Herv{\'e} and Lamy, Thierry and Fruchart, Christophe and Le Gouill, Steven and Thieblemont, Catherine and Morschhauser, Franck and Casasnovas, Olivier and Bouabdallah, Krimo and Ghesquieres, Herve and van den Neste, Eric and Andre, Marc and Cartron, Guillaume and Salles, Gilles},
URL = {https://hal.science/hal-03660656},
JOURNAL = {Cancers},
PUBLISHER = {MDPI},
VOLUME = {14},
NUMBER = {7},
PAGES = {1761},
YEAR = {2022},
MONTH = Mar, DOI = {10.3390/cancers14071761},
KEYWORDS = {relapsed ; refractory non-Hodgkin B-cell lymphoma ; ibrutinib ; R-DHAP ; R-DHAOx ; safety},
PDF = {https://hal.science/hal-03660656/file/cancers-14-01761.pdf},
HAL_ID = {hal-03660656},
HAL_VERSION = {v1},
}